drugset / Trial / NCT01261065
Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
NaSingle-groupOpen-labelDiagnostic
Summary
The overall hypothesis of this application is that the improvement in LV ejection performance following treatment with betablockers is due, at least in part, to improvement in intrinsic myocardial contractility.
Timeline
- Start
- 2001-12
- Primary completion
- 2005-10
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 25 mg | — |
| Subject | Carvedilol | Other / unclassified | 37.5 mg | — |